Valeant Pharmaceuticals International (VRX) 26.30 $VRX
Marvell Technologies Delays 10-K Filing; Shares Slip
at The Street - Thu Mar 31, 5:23PM CDT
The semiconductor maker also said its revenue for the year will be down signficantly, and that it will post a loss due to the settlement of litigation.
VRX: 26.30 (-0.77), MRVL: 10.31 (-0.01)
Bill Ackman Couldn't Sell Valeant Now if He Tried; Regulators Halt Exec Trading
at The Street - Thu Mar 31, 2:35PM CDT
It doesn't bode well that many officers at the troubled Canadian drugmaker were barred from trading their shares Thursday.
VRX: 26.30 (-0.77)
Valeant (VRX) Stock Retreats Amid Potential of Not Meeting SEC, NYSE Obligations
at The Street - Thu Mar 31, 12:57PM CDT
Valeant (VRX) stock is down this afternoon as an extension to its 10-K filing deadline could nonetheless result in it not meeting reporting obligations with the SEC and NYSE.
VRX: 26.30 (-0.77)
Valeant Pharmaceuticals (VRX) Still a Strong Sell Stock
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 9:02AM CDT
Valeant (VRX) stock remains Strong Sell in Zacks.
VRX: 26.30 (-0.77), WBA: 84.24 (+0.61), EBS: 36.35 (+1.13), AMAG: 23.40 (+1.28)
Medivation Surges on Takeover Chatter; Wall Street Scouts for Big Pharma M&A
at The Street - Thu Mar 31, 7:10AM CDT
Medivation is surging as Wall Street scouts the Big Pharma front for discounted M&A opportunities.
MDVN: 45.98 (+8.59), JNJ: 108.20 (-0.78), VRX: 26.30 (-0.77)
Stocks Close at Highest Level of 2016 in Day Two of Rally
at The Street - Wed Mar 30, 3:04PM CDT
Good vibes over a dovish Federal Reserve overflowed into Wednesday's session, extending the rally on Tuesday that pushed stocks back into positive territory for the year.
VRX: 26.30 (-0.77), SONC: 35.16 (+0.58), AAPL: 108.99 (-0.57), LULU: 67.71 (-0.09)
Stocks Modestly Higher as Crude Rally Stalls
at The Street - Wed Mar 30, 1:49PM CDT
Stocks are just modestly higher by late Wednesday afternoon as a rally in crude oil quickly runs out of steam.
VRX: 26.30 (-0.77), SONC: 35.16 (+0.58), BA: 126.94 (-1.64), AAPL: 108.99 (-0.57), LULU: 67.71 (-0.09)
Bill Ackman Sees U-Turn at Valeant, Pershing Square's Biggest Flop so Far
at The Street - Wed Mar 30, 11:47AM CDT
The billionaire activist has no shortage of investment blunders, but shareholders can learn a lot from his biggest flop to date.
HLF: 61.56 (+0.18), VRX: 26.30 (-0.77), JCP: 11.06 (-0.16)
Jim Cramer: Valeant (VRX) Stock 'Not so Hot' Amid Possible 10-K Filing Extension
at The Street - Wed Mar 30, 11:46AM CDT
Valeant (VRX) stock is dropping in midday trading on Wednesday after the company announced that it's asking for a waiver to its credit facility.
VRX: 26.30 (-0.77)
Jim Cramer -- Avoid Valeant, Shake Shack Costs Way Too Much
at The Street - Wed Mar 30, 10:20AM CDT
Cramer says there are better stocks out there than Valeant and Shake Shack has yet to grow into its market cap.
VRX: 26.30 (-0.77), SHAK: 37.32 (+1.55), BMY: 63.88 (+0.44)
Stocks Hold Highs as Oil Jumps on Smaller Inventory Build
at The Street - Wed Mar 30, 10:02AM CDT
Stocks hold session highs by late morning Wednesday as a smaller build in crude inventories pushes oil prices closer to the $40-mark.
VRX: 26.30 (-0.77), SONC: 35.16 (+0.58), BP: 30.18 (-0.75), CVX: 95.40 (+0.15), BA: 126.94 (-1.64), AAPL: 108.99 (-0.57), SLB: 73.75 (-0.66), LULU: 67.71 (-0.09), XLE: 61.89 (-0.03)
Valeant tries to delay release of financial statements
AP - Wed Mar 30, 9:52AM CDT
NEW YORK (AP) — Troubled Valeant Pharmaceuticals said Wednesday that it wants to delay the release of its financial statements by several weeks to avoid a default of its loans.
VRX: 26.30 (-0.77), VRX.TO: 34.05 (-1.05)
Janet Yellen's Dovish Interest Rate Stance Lifts Markets, Oil
at The Street - Wed Mar 30, 7:35AM CDT
U.S. futures are looking to continue yesterday's rally; Boeing announces job cuts.
GE: 31.79 (-0.04), VRX: 26.30 (-0.77), STT: 58.52 (unch), BA: 126.94 (-1.64), LULU: 67.71 (-0.09)
Stock Futures Maintain Highs After Private Sector Adds 200,000 Jobs
at The Street - Wed Mar 30, 7:23AM CDT
Stock futures hold gains on Wednesday morning after an unofficial read on the labor market shows a substantial increase in private-sector jobs.
VRX: 26.30 (-0.77), SONC: 35.16 (+0.58), BA: 126.94 (-1.64), LULU: 67.71 (-0.09)
Valeant Pharmaceuticals Launches Credit Facility Amendment
CNW Group - Wed Mar 30, 6:00AM CDT
Intends to File 10-K on or before April 29, 2016, as Previously Disclosed
VRX: 26.30 (-0.77), VRX.TO: 34.05 (-1.05)
EyeGate Reports Full-year 2015 Financial Results and Provides Business Update
GlobeNewswire - Tue Mar 29, 3:45PM CDT
Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or the "Company"
, a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today announced financial results for the twelve-month period ended December 31, 2015 and provided an update on recent strategic and operational initiatives.
VRX: 26.30 (-0.77), EYEG: 3.08 (+0.06), VRX.TO: 34.05 (-1.05)
Valeant CEO Gets Subpoena from Senate Aging Committee
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 3:45PM CDT
Shares of Valeant Pharmaceuticals International, Inc. (VRX) dropped 7.2% after the company's CEO received a subpoena from the Senate Aging Committee amid the ongoing mess.
VRX: 26.30 (-0.77), ARQL: 1.60 (+0.02), SCMP: 10.93 (+0.57), CORT: 4.68 (+0.41)
Pricey prostate cancer drug's makers targeted by Congress
BY LINDA A. JOHNSON - AP - Tue Mar 29, 11:12AM CDT
TRENTON, N.J. (AP) — Lawmakers again are targeting the pharmaceutical industry over sky-high prescription drug prices, a hot issue this year in Washington and on the campaign trail that's been dragging down stock prices of many drugmakers.
MDVN: 45.98 (+8.59), VRX: 26.30 (-0.77), VRX.TO: 34.05 (-1.05)
The Valeant Saga Triggers Buying Opportunities in Biotech Stocks
at The Street - Tue Mar 29, 10:30AM CDT
Other companies have suffered following the debacle.
AGN: 268.03 (-6.91), PRGO: 127.93 (-1.69), VRX: 26.30 (-0.77), MYL: 46.35 (-0.05), TEVA: 53.51 (-0.89)
Marvell Technologies Delays 10-K Filing; Shares Slip
at The Street - Thu Mar 31, 5:23PM CDT
The semiconductor maker also said its revenue for the year will be down signficantly, and that it will post a loss due to the settlement of litigation.
VRX: 26.30 (-0.77), MRVL: 10.31 (-0.01)
Bill Ackman Couldn't Sell Valeant Now if He Tried; Regulators Halt Exec Trading
at The Street - Thu Mar 31, 2:35PM CDT
It doesn't bode well that many officers at the troubled Canadian drugmaker were barred from trading their shares Thursday.
VRX: 26.30 (-0.77)
Valeant (VRX) Stock Retreats Amid Potential of Not Meeting SEC, NYSE Obligations
at The Street - Thu Mar 31, 12:57PM CDT
Valeant (VRX) stock is down this afternoon as an extension to its 10-K filing deadline could nonetheless result in it not meeting reporting obligations with the SEC and NYSE.
VRX: 26.30 (-0.77)
Valeant Pharmaceuticals (VRX) Still a Strong Sell Stock
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 9:02AM CDT
Valeant (VRX) stock remains Strong Sell in Zacks.
VRX: 26.30 (-0.77), WBA: 84.24 (+0.61), EBS: 36.35 (+1.13), AMAG: 23.40 (+1.28)
Medivation Surges on Takeover Chatter; Wall Street Scouts for Big Pharma M&A
at The Street - Thu Mar 31, 7:10AM CDT
Medivation is surging as Wall Street scouts the Big Pharma front for discounted M&A opportunities.
MDVN: 45.98 (+8.59), JNJ: 108.20 (-0.78), VRX: 26.30 (-0.77)
Stocks Close at Highest Level of 2016 in Day Two of Rally
at The Street - Wed Mar 30, 3:04PM CDT
Good vibes over a dovish Federal Reserve overflowed into Wednesday's session, extending the rally on Tuesday that pushed stocks back into positive territory for the year.
VRX: 26.30 (-0.77), SONC: 35.16 (+0.58), AAPL: 108.99 (-0.57), LULU: 67.71 (-0.09)
Stocks Modestly Higher as Crude Rally Stalls
at The Street - Wed Mar 30, 1:49PM CDT
Stocks are just modestly higher by late Wednesday afternoon as a rally in crude oil quickly runs out of steam.
VRX: 26.30 (-0.77), SONC: 35.16 (+0.58), BA: 126.94 (-1.64), AAPL: 108.99 (-0.57), LULU: 67.71 (-0.09)
Bill Ackman Sees U-Turn at Valeant, Pershing Square's Biggest Flop so Far
at The Street - Wed Mar 30, 11:47AM CDT
The billionaire activist has no shortage of investment blunders, but shareholders can learn a lot from his biggest flop to date.
HLF: 61.56 (+0.18), VRX: 26.30 (-0.77), JCP: 11.06 (-0.16)
Jim Cramer: Valeant (VRX) Stock 'Not so Hot' Amid Possible 10-K Filing Extension
at The Street - Wed Mar 30, 11:46AM CDT
Valeant (VRX) stock is dropping in midday trading on Wednesday after the company announced that it's asking for a waiver to its credit facility.
VRX: 26.30 (-0.77)
Jim Cramer -- Avoid Valeant, Shake Shack Costs Way Too Much
at The Street - Wed Mar 30, 10:20AM CDT
Cramer says there are better stocks out there than Valeant and Shake Shack has yet to grow into its market cap.
VRX: 26.30 (-0.77), SHAK: 37.32 (+1.55), BMY: 63.88 (+0.44)
Stocks Hold Highs as Oil Jumps on Smaller Inventory Build
at The Street - Wed Mar 30, 10:02AM CDT
Stocks hold session highs by late morning Wednesday as a smaller build in crude inventories pushes oil prices closer to the $40-mark.
VRX: 26.30 (-0.77), SONC: 35.16 (+0.58), BP: 30.18 (-0.75), CVX: 95.40 (+0.15), BA: 126.94 (-1.64), AAPL: 108.99 (-0.57), SLB: 73.75 (-0.66), LULU: 67.71 (-0.09), XLE: 61.89 (-0.03)
Valeant tries to delay release of financial statements
AP - Wed Mar 30, 9:52AM CDT
NEW YORK (AP) — Troubled Valeant Pharmaceuticals said Wednesday that it wants to delay the release of its financial statements by several weeks to avoid a default of its loans.
VRX: 26.30 (-0.77), VRX.TO: 34.05 (-1.05)
Janet Yellen's Dovish Interest Rate Stance Lifts Markets, Oil
at The Street - Wed Mar 30, 7:35AM CDT
U.S. futures are looking to continue yesterday's rally; Boeing announces job cuts.
GE: 31.79 (-0.04), VRX: 26.30 (-0.77), STT: 58.52 (unch), BA: 126.94 (-1.64), LULU: 67.71 (-0.09)
Stock Futures Maintain Highs After Private Sector Adds 200,000 Jobs
at The Street - Wed Mar 30, 7:23AM CDT
Stock futures hold gains on Wednesday morning after an unofficial read on the labor market shows a substantial increase in private-sector jobs.
VRX: 26.30 (-0.77), SONC: 35.16 (+0.58), BA: 126.94 (-1.64), LULU: 67.71 (-0.09)
Valeant Pharmaceuticals Launches Credit Facility Amendment
CNW Group - Wed Mar 30, 6:00AM CDT
Intends to File 10-K on or before April 29, 2016, as Previously Disclosed
VRX: 26.30 (-0.77), VRX.TO: 34.05 (-1.05)
EyeGate Reports Full-year 2015 Financial Results and Provides Business Update
GlobeNewswire - Tue Mar 29, 3:45PM CDT
Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or the "Company"
, a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today announced financial results for the twelve-month period ended December 31, 2015 and provided an update on recent strategic and operational initiatives. VRX: 26.30 (-0.77), EYEG: 3.08 (+0.06), VRX.TO: 34.05 (-1.05)
Valeant CEO Gets Subpoena from Senate Aging Committee
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 3:45PM CDT
Shares of Valeant Pharmaceuticals International, Inc. (VRX) dropped 7.2% after the company's CEO received a subpoena from the Senate Aging Committee amid the ongoing mess.
VRX: 26.30 (-0.77), ARQL: 1.60 (+0.02), SCMP: 10.93 (+0.57), CORT: 4.68 (+0.41)
Pricey prostate cancer drug's makers targeted by Congress
BY LINDA A. JOHNSON - AP - Tue Mar 29, 11:12AM CDT
TRENTON, N.J. (AP) — Lawmakers again are targeting the pharmaceutical industry over sky-high prescription drug prices, a hot issue this year in Washington and on the campaign trail that's been dragging down stock prices of many drugmakers.
MDVN: 45.98 (+8.59), VRX: 26.30 (-0.77), VRX.TO: 34.05 (-1.05)
The Valeant Saga Triggers Buying Opportunities in Biotech Stocks
at The Street - Tue Mar 29, 10:30AM CDT
Other companies have suffered following the debacle.
AGN: 268.03 (-6.91), PRGO: 127.93 (-1.69), VRX: 26.30 (-0.77), MYL: 46.35 (-0.05), TEVA: 53.51 (-0.89)
